BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Monday, May 6, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 20, 2014
View Archived Issues
Phase II results show vismodegib is well tolerated in patients with mPDA
Read More
Kissei gains approval for Savene in Japan
Read More
XBiotech launches phase II study in rare disorder pyoderma gangrenosum
Read More
AstraZeneca and Bristol-Myers Squibb Diabetes Alliance awards grant to ADA
Read More
Oryzon cleared to begin phase I/IIa trial of ORY-1001 in the U.K.
Read More
Researchers in the U.S. prepare new GWT1 inhibitors for fungal infections
Read More
Novel ALK/c-Met inhibitors disclosed by Concert Pharmaceuticals
Read More
Novel biomarkers for breast cancer prognosis identified and evaluated
Read More
Dart NeuroScience discloses novel PDE1B inhibitors
Read More
Inhibition of immune cell priming to ameliorate autoimmune inflammatory diseases
Read More
Scientists at Merck & Co. patent new SYK inhibitors
Read More
Development of a novel class of tau ligands for medical imaging of AD
Read More
Aniona prepares novel GABA(A) modulators
Read More
Researchers at Bristol-Myers Squibb design new monoclonal antibodies
Read More
NovoEight obtains Japanese approval
Read More
Giotrif approved in Japan for patients with NSCLC and EGFR mutation
Read More
FDA extends review of Trimel's NDA for CompleoTRT
Read More
Karyopharm targets PAK-4 in pancreatic cancer
Read More
Sovaldi approved in Europe for treatment of chronic HCV infection
Read More
Shire sells Dermagraft assets to Organogenesis
Read More
Kyowa Hakko Kirin obtains approval for new formulation of antiepileptic agent in Japan
Read More
Ariad's Iclusig now commercially available in U.S.
Read More
Acerta Pharma launches phase I trial of novel BTK inhibitor in CLL
Read More
Mitsubishi Tanabe files for use of Telavic in additional indication in Japan
Read More
Biocon launches biosimilar version of Herceptin in India
Read More